Page last updated: 2024-10-24

caffeine and Tachycardia, Ventricular

caffeine has been researched along with Tachycardia, Ventricular in 34 studies

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by life threatening arrhythmias and mutations in the gene encoding the ryanodine receptor (RyR2)."3.73Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. ( Colombi, B; Imbriani, M; Lai, FA; Liu, N; Memmi, M; Napolitano, C; Negri, S; Priori, SG; Rizzi, N; Zissimopoulos, S, 2006)
"Ventricular ectopic beats are commonly seen in daily clinical practice."2.48RETRACTED: Ventricular Ectopic Beats: An Overview of Management Considerations ( Chockalingam, A; Ingole, A; Jadhav, A, 2012)
"Serious complications included 2 seizures and 1 episode of ventricular tachycardia."1.48Energy drink exposures reported to Texas poison centers: Analysis of adverse incidents in relation to total sales, 2010-2014. ( Baeza, S; Borron, SW; Herrera, J; Kingston, RL; Larson, J; Watts, SH, 2018)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion."1.42Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. ( Arad, M; Barad, L; Binah, O; Eisen, B; Eldar, M; Eldor, L; Gherghiceanu, M; Itskovitz-Eldor, J; Lorber, A; Novak, A; Reiter, I, 2015)
"Caffeine is an easily available drug which is generally regarded as being safe."1.40Caffeine intoxication successfully treated by hemoperfusion and hemodialysis. ( Fukasawa, H; Furuya, R; Ishigaki, S; Kinoshita-Katahashi, N; Kumagai, H; Yasuda, H, 2014)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes."1.39Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. ( Faggioni, M; Hwang, HS; Kannankeril, PJ; Knollmann, BC; Nederend, I; van der Werf, C; Wilde, AA, 2013)
"Paroxysmal supraventricular tachycardia (PSVT) on electrocardiographic monitoring was found."1.38Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard. ( Aćimović, L; Babić, G; Ercegović, GV; Janković, S; Segrt, Z; Vukcević, NP, 2012)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2."1.36Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. ( Doi, M; Ikeda, Y; Ikemoto, N; Kobayashi, S; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Ono, M; Suetomi, T; Tateishi, H; Uchinoumi, H; Xu, X; Yamamoto, T; Yano, M, 2010)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by adrenergically mediated polymorphic ventricular tachycardia leading to syncope and sudden cardiac death."1.33Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. ( Cerrone, M; Colombi, B; di Barletta, MR; Napolitano, C; Priori, SG; Santoro, M; Scelsi, M; Villani, L, 2005)

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (5.88)18.2507
2000's16 (47.06)29.6817
2010's15 (44.12)24.3611
2020's1 (2.94)2.80

Authors

AuthorsStudies
Harsten, R1
Tetlow, SJ1
Chan, T1
Ankuli, A1
Zhong, X2
Vallmitjana, A2
Sun, B1
Xiao, Z1
Guo, W1
Wei, J1
Ni, M1
Chen, Y1
O'Brien, ER1
Gillis, AM1
Hoshijima, M1
Takeshima, H1
Hove-Madsen, L2
Benitez, R2
Belke, D1
Wayne Chen, SR1
Borron, SW1
Watts, SH1
Herrera, J1
Larson, J1
Baeza, S1
Kingston, RL1
Sahashi, Y1
Naruse, G1
Okura, H1
Zhang, XH1
Haviland, S1
Wei, H1
Sarić, T1
Fatima, A1
Hescheler, J1
Cleemann, L1
Morad, M1
Bai, Y1
Jones, PP1
Guo, J1
Clark, RB1
Zhou, Q1
Wang, R1
Semeniuk, L1
Guo, A1
Song, LS1
Duff, HJ1
Chen, SR2
Ishigaki, S1
Fukasawa, H1
Kinoshita-Katahashi, N1
Yasuda, H1
Kumagai, H1
Furuya, R1
Tsai, WC1
Lu, YY1
Chen, YC1
Chang, CJ1
Kao, YH1
Lin, YK1
Chen, YH1
Chen, SA1
Yang, LY1
Chen, YJ1
Novak, A1
Barad, L1
Lorber, A1
Gherghiceanu, M1
Reiter, I1
Eisen, B1
Eldor, L1
Itskovitz-Eldor, J1
Eldar, M1
Arad, M1
Binah, O1
Laskowski, LK1
Henesch, JA1
Nelson, LS1
Hoffman, RS1
Smith, SW1
Richards, JR1
Ramoska, EA1
Sand, IC1
Cua, WL1
Pease Campbell, JA1
Stewart, JT1
Fernández-Velasco, M1
Rueda, A1
Rizzi, N2
Benitah, JP1
Colombi, B3
Napolitano, C3
Priori, SG3
Richard, S1
Gómez, AM1
Uchinoumi, H1
Yano, M1
Suetomi, T1
Ono, M1
Xu, X1
Tateishi, H1
Oda, T1
Okuda, S1
Doi, M1
Kobayashi, S1
Yamamoto, T1
Ikeda, Y1
Ohkusa, T1
Ikemoto, N1
Matsuzaki, M1
Jadhav, A1
Ingole, A1
Chockalingam, A1
Shan, J1
Xie, W1
Betzenhauser, M1
Reiken, S1
Chen, BX1
Wronska, A1
Marks, AR1
Vukcević, NP1
Babić, G1
Segrt, Z1
Ercegović, GV1
Janković, S1
Aćimović, L1
Faggioni, M1
Hwang, HS1
van der Werf, C1
Nederend, I1
Kannankeril, PJ2
Wilde, AA1
Knollmann, BC1
Jiang, D1
Xiao, B1
Zhang, L1
George, CH2
Higgs, GV1
Lai, FA3
Goldhaber, JI1
Xie, LH1
Duong, T1
Motter, C1
Khuu, K1
Weiss, JN1
Cerrone, M1
Santoro, M1
di Barletta, MR1
Scelsi, M1
Villani, L1
Nam, GB1
Burashnikov, A1
Antzelevitch, C1
Balasubramaniam, R1
Chawla, S1
Grace, AA1
Huang, CL1
Jundi, H1
Walters, N1
Thomas, NL1
West, RR1
Liu, N1
Memmi, M1
Zissimopoulos, S1
Negri, S1
Imbriani, M1
Mitchell, BM1
Goonasekera, SA1
Chelu, MG1
Zhang, W1
Sood, S1
Kearney, DL1
Danila, CI1
De Biasi, M1
Wehrens, XH1
Pautler, RG1
Roden, DM1
Taffet, GE1
Dirksen, RT1
Anderson, ME1
Hamilton, SL1
Ng, GA1
Paavola, J1
Viitasalo, M1
Laitinen-Forsblom, PJ1
Pasternack, M1
Swan, H1
Tikkanen, I1
Toivonen, L1
Kontula, K1
Laine, M1
Dirksen, WP1
Lacombe, VA1
Chi, M1
Kalyanasundaram, A1
Viatchenko-Karpinski, S1
Terentyev, D1
Zhou, Z1
Vedamoorthyrao, S1
Li, N1
Chiamvimonvat, N1
Carnes, CA1
Franzini-Armstrong, C1
Györke, S1
Periasamy, M1
Fujiyoshi, N1
Yoshioka, T1
Morimoto, F1
Suzuki, Y1
Sueyoshi, K1
Shibuya, M1
Shimazaki, J1
Ishida, S1
Ito, M1
Takahashi, N1
Fujino, T1
Akimitsu, T1
Saikawa, T1
Aizaki, T1
Osaka, M1
Hara, H1
Kurokawa, S1
Matsuyama, K1
Aoyama, N1
Soma, K1
Ohwada, T1
Izumi, T1
Marchlinski, FE1
Deely, MP1
Zado, ES1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry[NCT05158751]100 participants (Anticipated)Observational2023-01-31Not yet recruiting
Role of a Novel Implantable Loop Recorder in the Management of Premature Ventricular Contractions[NCT06060548]50 participants (Anticipated)Observational2022-04-20Recruiting
Risk Stratifications for Patients Come With Palpitations in Assiut and Suez Canal University Hospitals[NCT06103305]208 participants (Anticipated)Observational2023-10-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for caffeine and Tachycardia, Ventricular

ArticleYear
RETRACTED: Ventricular Ectopic Beats: An Overview of Management Considerations
    The American journal of the medical sciences, 2012, Volume: 343, Issue:2

    Topics: Caffeine; Catheter Ablation; Exercise; Heart Ventricles; Humans; Hypertension; Prevalence; Tachycard

2012
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
Treating patients with ventricular ectopic beats.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:11

    Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia,

2006
[Case of caffeine poisoning survived by percutaneous cardio-pulmonary support].
    Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2008, Volume: 21, Issue:1

    Topics: Adolescent; Caffeine; Cardiopulmonary Resuscitation; Electric Countershock; Female; Humans; Tachycar

2008

Other Studies

31 other studies available for caffeine and Tachycardia, Ventricular

ArticleYear
Intralipid and haemodialysis in caffeine overdose.
    BMJ case reports, 2020, May-14, Volume: 13, Issue:5

    Topics: Acidosis; Adult; Anti-Arrhythmia Agents; Caffeine; Drug Overdose; Emulsions; Fat Emulsions, Intraven

2020
Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternans.
    The Biochemical journal, 2018, 01-05, Volume: 475, Issue:1

    Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Signaling; Cardiomegaly; Death, Sudden, Cardi

2018
Energy drink exposures reported to Texas poison centers: Analysis of adverse incidents in relation to total sales, 2010-2014.
    Regulatory toxicology and pharmacology : RTP, 2018, Volume: 97

    Topics: Caffeine; Child; Child, Preschool; Commerce; Energy Drinks; Female; Humans; Male; Retrospective Stud

2018
Three Different Types of Tachyarrhythmia and QT Prolongation in a Suicide Attempt.
    Circulation, 2019, 06-04, Volume: 139, Issue:23

    Topics: Action Potentials; Atrial Fibrillation; Caffeine; Drug Overdose; Electrocardiography; Female; Heart

2019
Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.
    Cell calcium, 2013, Volume: 54, Issue:2

    Topics: Adrenergic Agonists; Adult; Caffeine; Calcium; Calcium Signaling; Catecholamines; Cell Differentiati

2013
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
    Circulation research, 2013, Aug-16, Volume: 113, Issue:5

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2013
Caffeine intoxication successfully treated by hemoperfusion and hemodialysis.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:23

    Topics: Adult; Caffeine; Central Nervous System Stimulants; Hemoperfusion; Humans; Male; Renal Dialysis; Sch

2014
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
    International journal of cardiology, 2015, Jun-15, Volume: 189

    Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gen

2015
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
    Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:8

    Topics: Base Sequence; Caffeine; Calcium Signaling; Calsequestrin; Cell Differentiation; Genotyping Techniqu

2015
Start me up! Recurrent ventricular tachydysrhythmias following intentional concentrated caffeine ingestion.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:8

    Topics: Adrenergic beta-Antagonists; Caffeine; Dietary Supplements; Electric Countershock; Electrocardiograp

2015
Beta-blocker treatment of caffeine-induced tachydysrhythmias.
    Clinical toxicology (Philadelphia, Pa.), 2016, Volume: 54, Issue:5

    Topics: Adrenergic beta-Antagonists; Caffeine; Catecholamines; Humans; Propanolamines; Tachycardia, Ventricu

2016
A case of ventricular tachycardia related to caffeine pretreatment.
    The journal of ECT, 2009, Volume: 25, Issue:1

    Topics: Aged; Bipolar Disorder; Caffeine; Convulsants; Electroconvulsive Therapy; Humans; Male; Premedicatio

2009
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Circulation research, 2009, Jan-30, Volume: 104, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Caffeine; Calcium Signaling; Cardiac Pacing, Artificial; Catechol

2009
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Circulation research, 2010, Apr-30, Volume: 106, Issue:8

    Topics: Animals; Caffeine; Calcium Signaling; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Disease

2010
Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
    Circulation research, 2012, Aug-31, Volume: 111, Issue:6

    Topics: Animals; Atrial Fibrillation; Caffeine; Calcium; Cardiac Pacing, Artificial; Cells, Cultured; Diseas

2012
Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard.
    Vojnosanitetski pregled, 2012, Volume: 69, Issue:8

    Topics: Caffeine; Electrocardiography; Female; Humans; Injections, Intradermal; Mesotherapy; Middle Aged; Ob

2012
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
    Circulation research, 2013, Feb-15, Volume: 112, Issue:4

    Topics: Adult; Animals; Atropine; Bradycardia; Caffeine; Calcium Signaling; Calsequestrin; Cardiac Pacing, A

2013
Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.
    Circulation research, 2002, Aug-09, Volume: 91, Issue:3

    Topics: Animals; Caffeine; Calcium; Calcium Signaling; Cell Line; Death, Sudden, Cardiac; Electric Conductiv

2002
Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    Circulation research, 2003, Sep-19, Volume: 93, Issue:6

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Caffeine; Calcium; Cell Line; Cresols; Humans; Isoprote

2003
Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling.
    Circulation research, 2005, Mar-04, Volume: 96, Issue:4

    Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Channels; Calcium Channels, L-Type; Calcium S

2005
Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.
    Circulation research, 2005, May-27, Volume: 96, Issue:10

    Topics: Animals; Caffeine; Disease Models, Animal; Electrocardiography; Epinephrine; Mice; Mutation; Ryanodi

2005
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
    Circulation, 2005, May-31, Volume: 111, Issue:21

    Topics: Action Potentials; Animals; Caffeine; Calcium; Catecholamines; Disease Models, Animal; Dogs; Dose-Re

2005
Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:4

    Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cytosol; Diltiazem; Electric Stimulation; Home

2005
Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction.
    Circulation research, 2006, Jan-06, Volume: 98, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Caffeine; Calcium; CHO Cells; Cricetinae; Death, Sudden, Cardiac; Flu

2006
Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
    Circulation research, 2006, Aug-04, Volume: 99, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Caffeine; Cells, Cultured; Epinephrine; Membrane Potentials; Mice; Mi

2006
Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Aug-08, Volume: 103, Issue:32

    Topics: Animals; Caffeine; Cardiomyopathies; Catecholamines; Central Nervous System Stimulants; Epinephrine;

2006
Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
    European heart journal, 2007, Volume: 28, Issue:9

    Topics: Action Potentials; Adrenergic Agonists; Adult; Caffeine; Calcium; Central Nervous System Stimulants;

2007
A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
    Cardiovascular research, 2007, Jul-01, Volume: 75, Issue:1

    Topics: Animals; Caffeine; Calcium; Calcium Signaling; Calsequestrin; Cardiotonic Agents; Death, Sudden, Car

2007
Caffeine induces ventricular tachyarrhythmias possibly due to triggered activity in rabbits in vivo.
    Japanese circulation journal, 1996, Volume: 60, Issue:3

    Topics: Animals; Blood Pressure; Caffeine; Calcium Channel Blockers; Catecholamines; Cyclic AMP; Drug Evalua

1996
Hypokalemia with syncope caused by habitual drinking of oolong tea.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:3

    Topics: Binding Sites; Caffeine; Electrocardiography; Feeding Behavior; Female; Follow-Up Studies; Heart Blo

1999
Sex-specific triggers for right ventricular outflow tract tachycardia.
    American heart journal, 2000, Volume: 139, Issue:6

    Topics: Adult; Aged; Bundle-Branch Block; Caffeine; Central Nervous System Stimulants; Contraceptive Agents,

2000